Charles River Laboratories | CRL - Current Assets

Stock Price
162.47
Daily Change
-6.45 -3.82%
Monthly
-26.93%
Yearly
-4.72%
Q1 Forecast
163.68

Charles River Laboratories reported $1.45B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.59B 341M Sep/2025
Align Technology USD 2.62B 82.47M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Bruker USD 2.21B 138.1M Dec/2025
Cardinal Health USD 39.23B 693M Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cigna USD 46.74B 2.01B Sep/2025
Concord Medical Services Hldg CNY 850.84M 91.04M Jun/2023
CVS Health USD 74.71B 2.4B Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.07B 106M Sep/2025
Elevance Health USD 63B 777M Dec/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Humana USD 32.73B 19M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
IQVIA Holdings USD 6.25B 270M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Lonza CHF 5.44B 113M Dec/2024
McKesson USD 59.7B 190M Dec/2025
Merck EUR 12.88B 680M Sep/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
UnitedHealth USD 95.07B 1.37B Sep/2025
Veradigm USD 810.77M 18M Sep/2022
Waters USD 1.99B 69.86M Dec/2025
West Pharmaceutical Services USD 1.98B 154.9M Dec/2025